TD ASSET MANAGEMENT INC - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 204 filers reported holding REATA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 2.50 and the average weighting 1.1%.

Quarter-by-quarter ownership
TD ASSET MANAGEMENT INC ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$672,936
-16.5%
6,600
-25.6%
0.00%0.0%
Q1 2023$806,279
+64.3%
8,868
-31.4%
0.00%0.0%
Q4 2022$490,831
+64.2%
12,920
+8.2%
0.00%
Q3 2022$299,000
-17.6%
11,9360.0%0.00%
Q2 2022$363,000
-17.7%
11,936
-11.3%
0.00%
Q1 2022$441,000
-52.7%
13,450
-62.0%
0.00%
-100.0%
Q4 2021$932,000
-65.1%
35,360
+33.3%
0.00%
-66.7%
Q3 2021$2,668,000
-20.5%
26,518
-0.9%
0.00%0.0%
Q2 2021$3,354,000
+13.7%
26,765
-9.5%
0.00%0.0%
Q1 2021$2,950,000
-11.1%
29,588
+10.2%
0.00%
-25.0%
Q4 2020$3,319,000
+62.2%
26,848
+27.9%
0.00%
+33.3%
Q3 2020$2,046,000
-34.4%
20,997
+5.0%
0.00%
-25.0%
Q2 2020$3,120,000
+2.5%
19,997
-5.2%
0.00%
-20.0%
Q1 2020$3,045,000
-55.0%
21,097
-36.3%
0.01%
-50.0%
Q4 2019$6,766,000
+207.0%
33,097
+20.6%
0.01%
+233.3%
Q3 2019$2,204,000
+18.4%
27,453
+39.1%
0.00%0.0%
Q2 2019$1,862,000
+37.7%
19,737
+24.8%
0.00%
+50.0%
Q1 2019$1,352,000
+54.3%
15,813
+1.3%
0.00%0.0%
Q4 2018$876,000
-30.0%
15,613
+2.0%
0.00%0.0%
Q3 2018$1,252,00015,3130.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Conrad N. Hilton Foundation 63,481$7,847,000100.00%
CPMG Inc 2,896,901$358,115,00055.16%
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE 140,000$17,307,00026.62%
Corriente Advisors, LLC 525,000$64,901,00015.45%
DUMAC, INC. 76,050$9,401,0007.33%
MADDEN SECURITIES Corp 35,152$4,345,0002.80%
Biondo Investment Advisors, LLC 113,692$14,055,0002.69%
Duquesne Family Office 749,897$92,702,0002.50%
LBJ Family Wealth Advisors, Ltd. 30,368$3,754,0002.44%
Integral Health Asset Management, LLC 50,000$6,181,0001.84%
View complete list of REATA PHARMACEUTICALS INC shareholders